Basic Information
Basic information for LINC00343-278-61aa
Peptide Name LINC00343-278-61aa
Genome Position chr13:105718553-105718559,105718648-105718823[+]
Species Human
Peptide Sequence MAALHGKKNGNNKISNSCQINGHKKEIIDCWQWWGKSYKNCLCTIFLLSSKIFTLAKVYNS
Peptide Length 61
Unique No (LINC00343-202-61aa,LINC00343-214-61aa,LINC00343-216-61aa,LINC00343-219-61aa,LINC00343-231-61aa,LINC00343-233-61aa,LINC00343-254-61aa,LINC00343-262-61aa,LINC00343-277-61aa,LINC00343-280-61aa,LINC00343-302-61aa,LINC00343-325-61aa,LINC00343-327-61aa,LINC00343-329-61aa)
Grand Average of Hydropathicity -0.3279
Relative Molecular Mass 8059.1
Experimental Evidences no
lncRNA ID/Name ENSG00000226620;LINC00343
Transcript ID/Name ENST00000665747;LINC00343-278
Transcript Length 1559
Coding Ability 0.6588
DNA Sequence Corresponding to Peptide ATGGCAGCTCTTCACGGAAAAAAAAATGGCAACAATAAAATCAGCAACTCCTGCCAAATAAATGGGCATAAAAAAGAAATCATAGACTGCTGGCAATGGTGGGGAAAAAGTTATAAAAATTGTCTCTGCACCATCTTCCTTTTGTCCTCTAAAATATTCACATTAGCAAAAGTATATAACAGC
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :